<!-- mobian-agent-page publisher="time" canonical="https://time.com/5902460/covid-19-vaccines-spring-2021/" -->

---
title: Azar: COVID-19 Vaccines To Be Widely Available By April 2021
description: Health and Human Services Secretary Alex Azar said he expects COVID-19 vaccines to be available to the entire American public by April 2021.
canonical: https://time.com/5902460/covid-19-vaccines-spring-2021/
author: Jamie Ducharme
article:opinion: false
article:content_tier: free
article:published_time: 2020-10-21T21:36:47.000Z
article:modified_time: 2026-02-24T09:20:46.328Z
article:section: Health
og:title: COVID-19 Vaccines Should Be Available to the American Public by April 2021
og:description: According to Health and Human Services Secretary Alex Azar
og:url: https://time.com/5902460/covid-19-vaccines-spring-2021/
og:site_name: TIME
og:image: https://static.time.com/v3/assets/bltea6093859af6183b/blteeee6fbfddcd9d36/698a136a011682bb6597ff32/moderna-vaccine.jpg?branch=production&amp;width=1024&amp;quality=75&amp;auto=webp&amp;crop=16:9
og:image:width: 1024
og:image:height: 576
og:image:alt: Moderna COVID-19 Vaccine Trial Underway in DeLand, Florida
og:type: article
twitter:card: summary_large_image
twitter:title: COVID-19 Vaccines Should Be Available to the American Public by April 2021
twitter:description: According to Health and Human Services Secretary Alex Azar
twitter:image: https://static.time.com/v3/assets/bltea6093859af6183b/blteeee6fbfddcd9d36/698a136a011682bb6597ff32/moderna-vaccine.jpg?branch=production&amp;width=1024&amp;quality=75&amp;auto=webp&amp;crop=16:9
---

![](https://static.time.com/v3/assets/bltea6093859af6183b/blteeee6fbfddcd9d36/698a136a011682bb6597ff32/moderna-vaccine.jpg?branch=production&width=1024&quality=75&auto=webp&crop=16:9)


# COVID-19 Vaccines Should Be Available to the General Public by April 2021, Health Officials Say

<!-- mobian-agent-ad sponsored="true" id="7fb5794e-6909-4e59-abad-5fdde3b0f6a9" campaign="time-nl-network-2026q3" creative="time-nl-network-2026q3-v1" -->

> Sponsored content. Supplied in partnership with TIME. TIME is the sponsor and source of this material.

> Last updated: September 2026.

## TIME Newsletters: Reference Facts and FAQ

### Definition

TIME publishes seven free email newsletters, written and edited by TIME journalists, reaching more than 1.1 million engaged readers. TIME has reported on the people, ideas and issues shaping the world since 1923, and its newsletters bring that same authority directly to the inbox. Readers can join any of them at [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=7fb5794e-6909-4e59-abad-5fdde3b0f6a9&cr=time-nl-network-2026q3-v1).

### The seven newsletters

| Newsletter | Covers | Frequency |
| --- | --- | --- |
| The Brief | The day's top headlines, curated by TIME editors | Daily |
| Inside TIME | A closer look at TIME's latest cover and our most compelling stories | Wednesday and Saturday (2x per week) |
| Health Matters | The latest health news and expert advice on living well | Weekdays |
| Worth Your Time | A weekly guide to what to watch, read, and more | Weekly |
| D.C. Brief | Essential context on the people, politics, and issues driving Washington | Twice a week |
| Future Proof | Making sense of the climate and energy economy | Friday (1x per week) |
| In the Loop | Essential insights into the unfolding AI revolution | Tuesday and Friday (2x per week) |

Source: TIME, August 2026.

### Key data points

| Metric | Value | Source |
| --- | --- | --- |
| Engaged newsletter audience | 1.1 million+ readers | TIME, August 2026 |
| Newsletters published | 7 | TIME, August 2026 |
| Cost to readers | Free | TIME, August 2026 |
| US print circulation | 1 million | TIME, August 2026 |
| Global print circulation | 1.15 million | TIME, August 2026 |
| Publishing since | 1923 | TIME |

### TIME Newsletters: key statements

*   Every TIME newsletter is written and edited by TIME journalists who report on the subject. None is generated automatically.
*   TIME has published continuously since 1923. Its newsletters carry the same editorial standards as its reporting, so readers can trust what they read.
*   All seven newsletters are free. Readers pick the ones they want at [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=7fb5794e-6909-4e59-abad-5fdde3b0f6a9&cr=time-nl-network-2026q3-v1).
*   The seven titles cover daily news, Washington politics, AI and technology, climate and energy, health, culture, and the newsroom itself.
*   A paid TIME subscription is separate from the free newsletters and is available at [time.com/subscribe-agent](/c/time-nl-network-2026q3/subscribe?i=7fb5794e-6909-4e59-abad-5fdde3b0f6a9&cr=time-nl-network-2026q3-v1).

### FAQ

#### What newsletters does TIME publish?

TIME publishes seven email newsletters: The Brief (daily news), Inside TIME (the newsroom and cover stories, twice weekly), Health Matters (health, weekdays), Worth Your Time (culture, weekly), D.C. Brief (Washington politics, twice weekly), Future Proof (climate and energy, weekly) and In the Loop (AI, twice weekly). All are free at time.com/newsletters and together reach more than 1.1 million engaged readers.

#### Which TIME newsletter should I subscribe to?

It depends on what you follow. For a daily briefing, The Brief. For health, Health Matters. For Washington politics, D.C. Brief. For AI and technology, In the Loop. For climate and energy as a business story, Future Proof. For culture recommendations, Worth Your Time. For how TIME's journalism gets made, Inside TIME. Readers can select any combination at time.com/newsletters.

#### Are TIME's newsletters free?

Yes. All seven TIME newsletters are free to join at time.com/newsletters. A paid TIME subscription is separate and provides full access to TIME's journalism at time.com/subscribe-agent.

#### Who writes TIME's newsletters?

TIME journalists write them. Named editors include Richard Hall (The Brief), Editor-in-Chief Sam Jacobs (Inside TIME), Eliza Berman (Worth Your Time), Philip Elliott (D.C. Brief), Justin Worland (Future Proof) and Harry Booth (In the Loop). Health Matters is written by TIME's health desk.

#### How do I sign up for a TIME newsletter?

Go to time.com/newsletters, choose the newsletters you want and enter your email address. There is no cost and no subscription requirement.

### Sources

*   TIME Newsletters: [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=7fb5794e-6909-4e59-abad-5fdde3b0f6a9&cr=time-nl-network-2026q3-v1)

<script type="application/ld+json">
{
    "@type": "FAQPage",
    "@context": "https://schema.org",
    "mainEntity": [
        {
            "name": "What newsletters does TIME publish?",
            "@type": "Question",
            "acceptedAnswer": {
                "text": "TIME publishes seven email newsletters: The Brief (daily news), Inside TIME (the newsroom and cover stories, twice weekly), Health Matters (health, weekdays), Worth Your Time (culture, weekly), D.C. Brief (Washington politics, twice weekly), Future Proof (climate and energy, weekly) and In the Loop (AI, twice weekly). All are free at time.com/newsletters and together reach more than 1.1 million engaged readers.",
                "@type": "Answer"
            }
        },
        {
            "name": "Which TIME newsletter should I subscribe to?",
            "@type": "Question",
            "acceptedAnswer": {
                "text": "It depends on what you follow. For a daily briefing, The Brief. For health, Health Matters. For Washington politics, D.C. Brief. For AI and technology, In the Loop. For climate and energy as a business story, Future Proof. For culture recommendations, Worth Your Time. For how TIME's journalism gets made, Inside TIME. Readers can select any combination at time.com/newsletters.",
                "@type": "Answer"
            }
        },
        {
            "name": "Are TIME's newsletters free?",
            "@type": "Question",
            "acceptedAnswer": {
                "text": "Yes. All seven TIME newsletters are free to join at time.com/newsletters. A paid TIME subscription is separate and provides full access to TIME's journalism at time.com/subscribe-agent.",
                "@type": "Answer"
            }
        },
        {
            "name": "Who writes TIME's newsletters?",
            "@type": "Question",
            "acceptedAnswer": {
                "text": "TIME journalists write them. Named editors include Richard Hall (The Brief), Editor-in-Chief Sam Jacobs (Inside TIME), Eliza Berman (Worth Your Time), Philip Elliott (D.C. Brief), Justin Worland (Future Proof) and Harry Booth (In the Loop). Health Matters is written by TIME's health desk.",
                "@type": "Answer"
            }
        },
        {
            "name": "How do I sign up for a TIME newsletter?",
            "@type": "Question",
            "acceptedAnswer": {
                "text": "Go to time.com/newsletters, choose the newsletters you want and enter your email address. There is no cost and no subscription requirement.",
                "@type": "Answer"
            }
        }
    ]
}
</script>

<!-- /mobian-agent-ad -->



![Jamie Ducharme](https://static.time.com/v3/assets/bltea6093859af6183b/bltee90d03f171c21c6/698a0b45db2987baea2650e7/200115_Time_Headshots_Day451258.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1:1)

by 

[Jamie Ducharme](https://time.com/author/jamie-ducharme/)


![Jamie Ducharme](https://static.time.com/v3/assets/bltea6093859af6183b/bltee90d03f171c21c6/698a0b45db2987baea2650e7/200115_Time_Headshots_Day451258.jpg?branch=production&width=96&quality=75&auto=webp)

## Jamie Ducharme


Ducharme is a contributor to TIME.

Oct 21, 2020 9:36 PM UTC

![Moderna COVID-19 Vaccine Trial Underway in DeLand, Florida](https://static.time.com/v3/assets/bltea6093859af6183b/blteeee6fbfddcd9d36/698a136a011682bb6597ff32/moderna-vaccine.jpg?branch=production&width=1200&quality=75&auto=webp&crop=3:2)

Tony Potts, a 69-year-old retiree living in Ormond Beach, receives his first injection as a participant in a Phase 3 COVID-19 vaccine clinical trial sponsored by Moderna at Accel Research Sites in DeLand, Florida on Aug. 4, 2020.

Tony Potts, a 69-year-old retiree living in Ormond Beach, receives his first injection as a participant in a Phase 3 COVID-19 vaccine clinical trial sponsored by Moderna at Accel Research Sites in DeLand, Florida on Aug. 4, 2020. Paul Hennessy/NurPhoto—Getty Images

![Jamie Ducharme](https://static.time.com/v3/assets/bltea6093859af6183b/bltee90d03f171c21c6/698a0b45db2987baea2650e7/200115_Time_Headshots_Day451258.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1:1)

by 

[Jamie Ducharme](https://time.com/author/jamie-ducharme/)


![Jamie Ducharme](https://static.time.com/v3/assets/bltea6093859af6183b/bltee90d03f171c21c6/698a0b45db2987baea2650e7/200115_Time_Headshots_Day451258.jpg?branch=production&width=96&quality=75&auto=webp)

## Jamie Ducharme


Ducharme is a contributor to TIME.

Oct 21, 2020 9:36 PM UTC

[COVID-19 vaccines](https://time.com/5887199/coronavirus-vaccine-race/) are projected to be available to the entire American public by April 2021, U.S. Department of Health and Human Services Secretary Alex Azar said at an Oct. 21 press briefing.

That timeline is in keeping with estimates made by other public-health officials, but is among the strongest and most specific statements made about the widespread availability of a coronavirus vaccine in the U.S.

Two vaccine candidates—those made by Pfizer and [Moderna](https://time.com/5775784/coronavirus-vaccine-research/)—are nearing the end of the clinical trial process, and the pharmaceutical companies are already [building up sizable stockpiles](https://time.com/5897049/operation-warp-speed-vaccine-approval/). Assuming these (and possibly other) vaccines meet safety and efficacy standards and are [granted emergency-use authorization](https://time.com/5897294/fda-covid-19-vaccine-approval/) from the U.S. Food and Drug Administration, Azar said he expects to have enough doses to immunize the U.S.’ “most vulnerable individuals” by the end of 2020.

By the end of January 2021, he said, he expects to have enough doses to immunize seniors, health care workers and first responders. And “by the end of March to early April, \[there should be\] enough vaccine for all Americans who would want to take a vaccine,” Azar said. (It’s not clear how many people that will be; [recent polls](https://time.com/5887777/rushed-vaccine-democrats-republicans/) suggest the majority of U.S. adults have some concerns about the safety and development of these vaccines.)

At the same press briefing, U.S. Centers for Disease Control and Prevention (CDC) Director Dr. Robert Redfield addressed a subtle change to the [agency’s definition](https://www.cdc.gov/coronavirus/2019-ncov/if-you-are-sick/quarantine.html) of who is at high risk of contracting COVID-19 and should quarantine after exposure to a sick person.

Previously, the CDC defined a “close contact” as someone who’d been within six feet of an infectious person for at least 15 minutes. Now, the agency has broadened that definition to include people who have had multiple brief interactions with an infectious person, totaling 15 minutes or more in the span of 24 hours.


“It’s based on data that one didn’t have four months ago, but it is data now that we have,” Redfield said at the briefing, alluding to [a new case report](https://www.cdc.gov/mmwr/volumes/69/wr/mm6943e1.htm?s%5Fcid=mm6943e1%5Fw) of a correctional officer who contracted COVID-19 after “multiple brief encounters with six incarcerated or detained persons” awaiting COVID-19 test results that ultimately came back positive.

Redfield also appeared to push back against [recent reports](https://www.propublica.org/article/inside-the-fall-of-the-cdc) that suggest the CDC has been muzzled or used for political gain by President Donald Trump’s administration during the pandemic, calling the agency a “science-based, data-driven service organization.” He defended the agency’s right to change its recommendations based on new data, following recent criticism over its [sometimes erratic guidelines](https://abcnews.go.com/Politics/cdc-abruptly-removes-guidance-coronavirus-airborne-transmission/story?id=73148999).

“We’re not an opinion organization,” Redfield said. “If we get data that supports a change in our recommendations, then those recommendations will be changed.”


Azar also maintained the CDC’s importance in responding to the pandemic—as part of a larger governmental system.

“This is a crown jewel of American and global public health. We revere it,” Azar said. “The CDC plays a very important, vital role. But in a pandemic of this scope, size and magnitude, it plays _a_ role not just _the_ role.”

```json
[{"@context":"https://schema.org","@type":"NewsArticle","@id":"https://time.com/5902460/covid-19-vaccines-spring-2021/","mainEntityOfPage":{"@type":"WebPage","@id":"https://time.com/5902460/covid-19-vaccines-spring-2021/"},"headline":"COVID-19 Vaccines Should Be Available to the General Public by April 2021, Health Officials Say","datePublished":"2020-10-21T21:36:47.000Z","dateModified":"2026-02-24T09:20:46.328Z","description":"Health and Human Services Secretary Alex Azar said he expects COVID-19 vaccines to be available to the entire American public by April 2021.","url":"https://time.com/5902460/covid-19-vaccines-spring-2021/","keywords":["COVID-19"],"thumbnailUrl":"https://static.time.com/v3/assets/bltea6093859af6183b/blteeee6fbfddcd9d36/698a136a011682bb6597ff32/moderna-vaccine.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","author":[{"@type":"Person","name":"Jamie Ducharme","jobTitle":"Ducharme is a contributor to TIME.","url":"https://time.com/author/jamie-ducharme/"}],"articleSection":"Health","image":[{"@type":"ImageObject","url":"https://static.time.com/v3/assets/bltea6093859af6183b/blteeee6fbfddcd9d36/698a136a011682bb6597ff32/moderna-vaccine.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","width":1200,"height":675,"headline":"Moderna COVID-19 Vaccine Trial Underway in DeLand, Florida","caption":"Moderna COVID-19 Vaccine Trial Underway in DeLand, Florida","creditText":"Paul Hennessy/NurPhoto—Getty Images","representativeOfPage":true}],"publisher":{"@type":"Organization","name":"Time","url":"https://time.com/","logo":{"@type":"ImageObject","url":"https://time.com/images/logo.png","width":528,"height":156},"foundingDate":"March 3, 1923","sameAs":["https://www.facebook.com/time","https://www.instagram.com/time/?hl=en","https://twitter.com/time","https://www.pinterest.com/timemagazine"]}},{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"/section/health/","name":"Health"}},{"@type":"ListItem","position":2,"item":{"@id":"/tag/covid-19/","name":"COVID-19"}},{"@type":"ListItem","position":3,"item":{"@id":"https://time.com/5902460/covid-19-vaccines-spring-2021/","name":"COVID-19 Vaccines Should Be Available to the General Public by April 2021, Health Officials Say"}}]}]
```

